BioSpace News Archive

Press Releases

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

September 2, 2026

·

4 min read

Huntington’s disease

UniQure files for FDA, UK approval of first gene therapy for Huntington’s disease

The biologics license application follows months of public speculation—and regulatory reversals—for uniQure’s AMT-130. If accepted by the FDA for priority review, approval could come in the second quarter of 2027.

September 2, 2026

·

3 min read

·

Heather McKenzie

Press Releases

AiM Medical Robotics Awarded $2 Million National Cancer Institute Grant to Advance MRI-Guided Robotic Treatment of Brain Cancer

September 2, 2026

·

9 min read

Press Releases

AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041

September 2, 2026

·

4 min read

Press Releases

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

September 2, 2026

·

1 min read

Press Releases

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer

September 2, 2026

·

4 min read

Press Releases

MannKind to Present at Upcoming September 2026 Investor Conferences

September 2, 2026

·

1 min read

Press Releases

ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange

September 2, 2026

·

6 min read

Press Releases

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th

September 2, 2026

·

10 min read

Press Releases

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

September 2, 2026

·

10 min read